首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer & metabolism

缩写:CANCER METAB

ISSN:N/A

e-ISSN:2049-3002

IF/分区:5.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引367
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Renaud Vatrinet,Giulia Leone,Monica De Luise et al. Renaud Vatrinet et al.
Deregulated metabolism is a well-established hallmark of cancer. At the hub of various metabolic pathways deeply integrated within mitochondrial functions, the α-ketoglutarate dehydrogenase complex represents a major modulator of electron ...
Rae-Anne Hardie,Ellen van Dam,Mark Cowley et al. Rae-Anne Hardie et al.
Background: Pancreatic cancer has a five-year survival rate of ~8%, with characteristic molecular heterogeneity and restricted treatment options. Targeting metabolism has emerged as a potentially effective therapeutic str...
Seher Balaban,Robert F Shearer,Lisa S Lee et al. Seher Balaban et al.
Background: Obesity is associated with increased recurrence and reduced survival of breast cancer. Adipocytes constitute a significant component of breast tissue, yet their role in provisioning metabolic substrates to sup...
Rachel S Kelly,Jennifer A Sinnott,Jennifer R Rider et al. Rachel S Kelly et al.
Background: Understanding the biologic mechanisms underlying the development of lethal prostate cancer is critical for improved therapeutic and prevention strategies. In this study we explored the role of tumor metabolism...
Parmanand Malvi,Balkrishna Chaube,Shivendra Vikram Singh et al. Parmanand Malvi et al.
Background: Obesity-related cellular, metabolic, and molecular alterations have been shown to increase cancer risk and tumor progression and are associated with poorer therapeutic outcome in cancer patients. However, the ...
Menghan Liu,Lake-Ee Quek,Ghazal Sultani et al. Menghan Liu et al.
Background: Pancreatic ductal adenocarcinoma (PDAC) is a common malignancy with dismal prognosis. Metastatic spread and therapeutic resistance, the main causes of PDAC-related mortalities, are both partially underlined by...
Stephanie Sprowl-Tanio,Amber N Habowski,Kira T Pate et al. Stephanie Sprowl-Tanio et al.
Background: There is increasing evidence that oncogenic Wnt signaling directs metabolic reprogramming of cancer cells to favor aerobic glycolysis or Warburg metabolism. In colon cancer, this reprogramming is due to direct...
Laura M Lashinger,Ciara H O&#x;Flanagan,Sarah M Dunlap et al. Laura M Lashinger et al.
Background: Calorie restriction (CR) prevents obesity and exerts anticancer effects in many preclinical models. CR is also increasingly being used in cancer patients as a sensitizing strategy prior to chemotherapy regimen...
Sergey Tumanov,Vinay Bulusu,Eyal Gottlieb et al. Sergey Tumanov et al.
Background: Acetyl-CoA is a key metabolic intermediate with roles in the production of energy and biomass, as well as in metabolic regulation. It was recently found that acetate is crucial for maintaining acetyl-CoA produ...
Mark A Keibler,Thomas M Wasylenko,Joanne K Kelleher et al. Mark A Keibler et al.
Background: The study of cancer metabolism has been largely dedicated to exploring the hypothesis that oncogenic transformation rewires cellular metabolism to sustain elevated rates of growth and division. Intense examina...